Reports of squamous cell carcinomas and various lymphomas in scar tissue around breast implants spurred the FDA to issue a recent safety alert。The risks appear to be rare， the agency said after conducting an initial review， noting that as of September 1， 2022， it had received 10 medical device reports about squamous cell carcinoma and 12 about various lymphomas related to breast implants that don’t necessarily represent unique cases。 A preliminary review of the published literature revealed fewer than 20 cases of the former and fewer than 30 cases of the latter， the FDA said。
NSTL
Amer Medical Assoc
